TechDogs-"BostonGene To Present Unique AI-Driven Bioinformatic Solutions At The Festival Of Genomics & Biodata"

BioTechnology

BostonGene To Present Unique AI-Driven Bioinformatic Solutions At The Festival Of Genomics & Biodata

By Business Wire

Business Wire
Overall Rating

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-based molecular and immune profiling solutions, announced today that it will participate in and present at the Festival of Genomics & Biodata, the world’s largest genomics & biodata annual meeting that brings together scientists, researchers, clinicians, technology companies, investors and patient organizations to realize the true potential of genomics medicine and related applications, which is being held October 5 - 6, 2023 in Boston, MA at the Boston Convention & Expo Center. BostonGene will also exhibit at booth 17.

BostonGene session details are below:

From Concept to Clinic: Developing unique AI-driven informatics solutions to power cancer discovery

  • Thursday, October 5, 2023 | 9:30 AM ET
  • Speaker: Nathan Fowler, MD, Chief Medical Officer, BostonGene
  • Location: Main stage

In this session, BostonGene will discuss how advances in next-generation sequencing have generated a wealth of unmined genomic data across myriad fields, including oncology. The presentation will cover comprehensive solutions that combine high-complexity bioinformatics, large throughput molecular and genomic CLIA/CAP technologies, and several large-scale databases to support early and late discovery projects.

To learn more or to schedule a meeting with BostonGene during the event, please contact Maria Proia at maria.proia@bostongene.com.

About BostonGene Corporation

BostonGene’s mission is to power healthcare’s transition to personalized medicine using our AI-based molecular and immune profiling to improve the standard of care, accelerate research, and reduce overall cost of cancer care. BostonGene’s tests reveal key drivers of each tumor, including immune microenvironment properties, actionable mutations, biomarkers of response to diverse therapies, and recommended therapies. Through these comprehensive analyses, BostonGene’s tests generate a personalized roadmap for therapeutic decision-making for each cancer patient. For more information, visit BostonGene at http://www.BostonGene.com.

Contacts

Media:

BostonGene
Erin O’Reilly
+1-617-283-2285
Erin.Oreilly@BostonGene.com

First published on Mon, Oct 2, 2023

Liked what you read? That’s only the tip of the tech iceberg!

Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!

Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.

Dive into TechDogs' treasure trove today and Know Your World of technology like never before!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs’ members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs’ Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. All information / content found on TechDogs’ site may not necessarily be reviewed by individuals with the expertise to validate its completeness, accuracy and reliability.

Tags:

BostonGene AI-based Molecular And Immune Profiling Solutions High-complexity Bioinformatics

References:

Join The Discussion

  • Dark
  • Light